Pelican has funded a large number of projects through its grant programme over the last two decades, with research awards totalling over £2 million.
Larger grants in the past were supported by government funding which Pelican no longer receives. In order to maximise the impact of its charitable donations, Pelican now aims to focus on providing pump-priming via small grants for pilot projects which have the potential to significantly improve patient care but are perhaps at too early a stage to attract grant funding from larger organisations. Several of the previously funded studies have led to the development of more ambitious projects which have subsequently received funding from the NIHR or Cancer Research UK. Early pilot data which is the result of the initial project funded by Pelican is often pivotal in attracting this funding.
Pelican Cancer Foundation is a member of the Association of Medical Research Charities (AMRC) and a non-commercial partner of the National Institute of Health Research (NIHR). All potential research studies are selected and monitored in line with AMRC recommendations, with oversight provided by the Pelican Research Review Panel (PRRP).
We’re delighted to have passed the AMRC Expert Review Audit in August 2025. By meeting the six principles of expert review, this demonstrates our commitment to using robust and rigorous funding processes which support high-quality research that help people with bowel cancer live well for longer and improves lives. Thank-you to everyone involved and the Pelican Cancer Foundation Research Grant Panel.
Expert Review Audit 2025 Certificate
Click here to view our current research projects
Click here to view our completed research projects
